퇴행성 디스크 치료 시장 : 기회 및 전략(-2035년)

Degenerative disc disease (DDD) treatment refers to the medical and therapeutic approaches used to manage symptoms caused by the gradual wear and tear of spinal intervertebral discs. The primary purpose of DDD treatment is to relieve pain, improve spinal function, and enhance quality of life. The treatment options range from conservative care to interventional and surgical methods, depending on severity and patient response.

The degenerative disc disease treatment market consists of sales of degenerative disc disease treatment by entities (organizations, sole traders and partnerships) that encompasses both pharmacological and non-pharmacological solutions. Pharmacological treatments often consist of conventional drugs such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, analgesics, and muscle relaxants, which help manage inflammation and pain. Novel therapies are also emerging, including regenerative medicine approaches such as stem cell therapy, platelet-rich plasma (PRP) injections, and gene therapies, which aim to restore or halt the degeneration of spinal discs. These therapies are frequently used in combination with physical therapy and other supportive care methods.

The global degenerative disc disease treatment market was valued at $18,628.1 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 9.00%.

Expansion Of Healthcare Expenditure

The expansion of healthcare expenditure supported the growth of the degenerative disc disease treatment market in the historic period. Increase in public and private healthcare spending improved access to diagnostic imaging, pain management therapies, and surgical interventions for spinal disorders. Higher budgets also allowed hospitals and clinics to adopt innovative treatment devices and minimally invasive procedures, enhancing clinical outcomes and patient throughput. Additionally, expanded healthcare funding improved reimbursement capacity and patient affordability, encouraging timely treatment adoption. From a business perspective, rising healthcare expenditure created a favorable environment for market expansion, supported higher procedure volumes, and drove revenue growth for degenerative disc disease treatment providers and manufacturers. For instance, in April 2025, according to the Office for National Statistics, a UK-based government department, reported that the UK's healthcare spending reached about $434.61 billion (£317 billion) in 2024. This represented a 6.5% increase compared to 2023 in nominal terms. After adjusting for inflation, healthcare expenditure still grew by 2.4% in real terms during the same period. Therefore, the expansion of healthcare expenditure drove the growth of the degenerative disc disease treatment market.

Artificial Intelligence And Autonomous Intelligence

Major companies operating in the degenerative disc disease treatment market are focusing on artificial intelligence-driven diagnostics and imaging analysis tools to improve early detection, classification, and treatment planning for lumbar spine degenerative conditions. For instance, in May 2024, The Radiological Society of North America (RSNA), a US-based non-profit organization, has launched the 2024 RSNA Lumbar Spine Degenerative Classification Artificial Intelligence (AI) Challenge, inviting global researchers to build artificial intelligence models that detect and classify degenerative lumbar spine conditions using MRI images. Developed with the American Society of Neuroradiology, a US-based organization and the American Society of Spine Radiology, a US-based organization, the competition uses the largest open-source annotated lumbar spine MRI dataset to date, with data from eight sites across five continents. Participants compete via a platform hosted by Kaggle, with the top nine teams sharing $50,000 in prize money. Successful artificial intelligence (AI) tools could enhance diagnostic accuracy and efficiency for lumbar degenerative conditions.

The global degenerative disc disease treatment market is fairly fragmented, with large number of small players operating across major regions. The top 10 competitors in the market made up 10.10% of the total market in 2024.

Degenerative Disc Disease Treatment Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global degenerative disc disease treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for degenerative disc disease treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The degenerative disc disease treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider degenerative disc disease treatment market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
• Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by treatment type, by disease type and by end user in the market. historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking Briefs on the financials comparison between major players in the market.
• Competitive Dashboard Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations This section includes recommendations for degenerative disc disease treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

• 1) By Treatment Type: Surgical; Pharmacological Treatment; Therapies
• 2) By Disease Type: Lumbar Degenerative Disk Disease; Cervical Degenerative Disk Disease; Multilevel Degenerative Disk Disease
• 3) By End User: Hospitals; Ambulatory Surgical Centers; Orthopedic Center
• Companies Mentioned: Medtronic plc; Johnson & Johnson (DePuy Synthes); Stryker Corp.; Globus Medical Inc.; B. Braun (Aesculap Implant Systems)
• Countries: China; Australia; India; Indonesia; Taiwan; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa; South East Asia
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; degenerative disc disease treatment indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Dashboard

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Degenerative Disc Disease Treatment Market Definition And Segmentations
• 6.4 Market Segmentation By Treatment Type (Surgical, Pharmacological Treatment And Therapies)
• 6.5 Market Segmentation By Disease Type (Oral And Injectable)
• 6.6 Market Segmentation By End User (Hospitals, Ambulatory Surgical Centers, And Orthopedic Centers)

7 Degenerative Disc Disease Treatment Market, Overview Of Key Products/Services

8 Global Degenerative Disc Disease Treatment Market Attractiveness Scoring And Analysis

• 8.1 Overview Of Market Attractiveness Framework
• 8.2 Quantitative Scoring Methodology
• 8.3 Market Attractiveness Scoring And Interpretation
• 8.4 Factor-Wise Evaluation
• 8.5 Growth Potential
  • 8.5.1 Competitive Dynamics
  • 8.5.2 Strategic Fit
  • 8.5.3 Risk Profile
  • 8.5.4 Strategic Implications And Recommendations
  • 8.5.5 Strategic Implications
  • 8.5.6 Strategic Recommendations

9 Degenerative Disc Disease Treatment Market, Supply Chain Analysis

• 9.1 Overview of the Supply Chain and Ecosystem
  • 9.1.1 Resources
  • 9.1.2 Manufacturers
  • 9.1.3 Distribution
  • 9.1.4 End Users

10 Major Market Trends

• 10.1 Key Technologies & Future Trends
  • 10.1.1 Artificial Intelligence And Autonomous Intelligence
  • 10.1.2 Biotechnology, Genomics And Precision Medicine
  • 10.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 10.1.4 Internet of Things (IoT), Smart Infrastructure And Connected Ecosystems
  • 10.1.5 Industry 4.0 And Intelligent Manufacturing
• 10.2 Major Trends
  • 10.2.1 Breakthrough In Tissue-Engineered, Motion-Preserving Disc Replacement
  • 10.2.2 Advancement Of Minimally Invasive Biologic Injection Through Large-Scale Clinical Evaluation
  • 10.2.3 Fast-Track Designation For Minimally Invasive Regenerative Back Pain Therapy
  • 10.2.4 Initiation Of U.S. Clinical Trial For Minimally Invasive Disc Restoration Therapy
  • 10.2.5 Regulatory Acceptance Of Phase III Program For Injectable Disc Regeneration Therapy

11 Global Degenerative Disc Disease Treatment Growth Analysis And Strategic Analysis Framework

• 11.1 Global Degenerative Disc Disease Treatment PESTEL Analysis
  • 11.1.1 Political
  • 11.1.2 Economic
  • 11.1.3 Social
  • 11.1.4 Technological
  • 11.1.5 Environmental
  • 11.1.6 Legal
• 11.2 Analysis Of End User (B2B) Market
  • 11.2.1 Hospitals
  • 11.2.2 Ambulatory Surgical Centers
  • 11.2.3 Orthopedic Center

12 Global Degenerative Disc Disease Treatment Market Size And Growth Analysis

• 12.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 12.1.1 Market Drivers 2020 - 2025
  • 12.1.2 Market Restraints 2020 - 2025
• 12.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 12.3 Forecast Growth Contributors/Factors
  • 12.3.1 Quantitative Growth Contributors
  • 12.3.2 Drivers
  • 12.3.3 Restraints

13 Global Degenerative Disc Disease Treatment Total Addressable Market (TAM) Analysis

• 13.1 Definition And Scope of Total Addressable Market (TAM)
• 13.2 Methodology And Assumptions
  • 13.2.1 Total Addressable Market for the Degenerative Disc Disease Treatment Market - Business to Customer (B2C)
  • 13.2.2 TAM Comparison Analysis

14 Global Degenerative Disc Disease Treatment Market Segmentation

• 14.1 Global Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.2 Global Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.3 Global Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.4 Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Surgical, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.5 Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Pharmacological Treatment, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.6 Global Degenerative Disc Disease Treatment Market, Sub-Segmentation Of Therapies, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Degenerative Disc Disease Treatment Market, Regional and Country Analysis

• 15.1 Global Degenerative Disc Disease Treatment Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.2 Global Degenerative Disc Disease Treatment Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Asia-Pacific Market

• 16.1 Asia-Pacific Market Summary
• 16.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.3 Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Asia-Pacific Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.6 China Market
  • 16.6.1 China Market Summary
  • 16.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.7 China Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.8 China Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.9 China Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.10 India Market
• 16.11 India Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.12 India Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.13 India Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.14 Japan Market
  • 16.14.1 Japan Market Summary
  • 16.14.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.15 Japan Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.16 Japan Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.17 Japan Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.18 Australia Market
• 16.19 Australia Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.20 Australia Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.21 Australia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.22 South Korea Market
  • 16.22.1 South Korea Market Summary
  • 16.22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.23 South Korea Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.24 South Korea Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.25 South Korea Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.26 Taiwan Market
• 16.27 Taiwan Market Summary
  • 16.27.1 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 16.28 Taiwan Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.29 Taiwan Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.30 Taiwan Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 South East Asia Market

• 17.1 South East Asia Market Summary
• 17.2 South East Asia Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.3 South East Asia Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 South East Asia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Indonesia Market
• 17.6 Indonesia Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.7 Indonesia Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.8 Indonesia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 North America Market

• 18.1 North America Market Summary
• 18.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.3 North America Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 North America Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 North America Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 USA Market
  • 18.6.1 USA Market Summary
  • 18.6.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.7 USA Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.8 USA Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.9 USA Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.10 Canada Market
  • 18.10.1 Canada Market Summary
  • 18.10.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 18.11 Canada Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.12 Canada Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.13 Canada Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 Western Europe Market

• 19.1 Western Europe Market Summary
• 19.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 19.3 Western Europe Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 Western Europe Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 Western Europe Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.6 UK Market
• 19.7 UK Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.8 UK Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.9 UK Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.10 Germany Market
• 19.11 Germany Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.12 Germany Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.13 Germany Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.14 France Market
• 19.15 France Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.16 France Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.17 France Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.18 Italy Market
• 19.19 Italy Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.20 Italy Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.21 Italy Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.22 Spain Market
• 19.23 Spain Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.24 Spain Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.25 Spain Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 South America Market

• 20.1 South America Market Summary
• 20.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 20.3 South America Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 South America Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 South America Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.6 Brazil Market
• 20.7 Brazil Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.8 Brazil Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.9 Brazil Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Eastern Europe Market

• 21.1 Eastern Europe Market Summary
• 21.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 21.3 Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.4 Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.5 Eastern Europe Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.6 Russia Market
• 21.7 Russia Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.8 Russia Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 21.9 Russia Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

22 Middle East Market

• 22.1 Middle East Market Summary
• 22.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 22.3 Middle East Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.4 Middle East Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 22.5 Middle East Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

23 Africa Market

• 23.1 Africa Market Summary
• 23.2 Market Overview (Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments And Major Companies)
• 23.3 Africa Degenerative Disc Disease Treatment Market, Segmentation By Treatment Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.4 Africa Degenerative Disc Disease Treatment Market, Segmentation By Disease Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 23.5 Africa Degenerative Disc Disease Treatment Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

24 Competitive Landscape And Company Profiles

• 24.1 Degenerative Disc Disease Treatment Market Competitive Landscape And & Market Share 2024
  • 24.1.1 Top 10 Companies (Ranked by revenue/share)
• 24.2 Company Profiles
• 24.3 Medtronic plc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 24.4 Johnson & Johnson (DePuy Synthes) (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 24.5 Stryker Corp (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 24.6 Globus Medical Inc (Company Overview, Products and Services, Business Strategy, Financial Overview)
• 24.7 B. Braun (Aesculap Implant Systems) (Company Overview, Products and Services, Business Strategy, Financial Overview)

25 Other Major And Innovative Companies

• 25.1 HIGHRIDGE Medical Inc. (Company Overview, Products and Services)
• 25.2 Orthofix Medical Inc. (Company Overview, Products and Services)
• 25.3 Arthrex Inc. (Company Overview, Products and Services)
• 25.4 Alphatec Holdings (ATEC) (Company Overview, Products and Services)
• 25.5 Spineart SA (Company Overview, Products and Services)
• 25.6 LifeNet Health Inc. (Company Overview, Products and Services)
• 25.7 RTI Surgical Holdings Inc. (Company Overview, Products and Services)
• 25.8 Spinal Elements Inc. (Company Overview, Products and Services)
• 25.9 Centinel Spine (Company Overview, Products and Services)
• 25.10 AstraZeneca PLC (Company Overview, Products and Services)
• 25.11 GlaxoSmithKline PLC (Company Overview, Products and Services)
• 25.12 Eli Lilly and Company (Company Overview, Products and Services)
• 25.13 Novartis AG (Company Overview, Products and Services)
• 25.14 Sanofi S.A. (Company Overview, Products and Services)
• 25.15 Teva Pharmaceutical Industrial Ltd. (Company Overview, Products and Services)

26 Competitive Benchmarking

27 Competitive Dashboard

28 Degenerative Disc Disease Treatment Market - Company Scoring Matrix

• 28.1 Innovation & Brand Leaders
• 28.2 Brand-Driven Traditionalists
• 28.3 Niche or Regional Followers
• 28.4 Emerging Innovators

29 Upcoming Startups In the Market

30 Qualitative Insights On The Ideal Patient Journey For Degenerative Disc Disease Treatment In Japan, USA And EU5 (Germany, France, Italy, Spain, UK)

• 30.1 Japan- Ideal Patient Journey for DDD Treatment
• 30.2 USA - Ideal Patient Journey for DDD Treatment
• 30.3 EU5 (Germany, France, Italy, Spain, UK) - Ideal Patient Journey for DDD Treatment

31 Estimates For Ideal Patient Journey For Degenerative Disc Disease Treatment

32 Key Mergers And Acquisitions

• 32.1 Companion Spine LLC Acquired Paradigm Spine GmbH
• 32.2 Companion Spine LLC Acquired Coflex And CoFix Spinal Implants And All OUS Businesses Of Xtant Medical Holdings Inc.
• 32.3 H.I.G. Capital Acquired Spine Business Of Zimvie Inc.

33 Recent Developments In Degenerative Disc Disease Treatment

• 33.1 Phase 3 Trial Initiation For Minimally Invasive Disc Regeneration Therapy

34 Opportunities And Strategies

• 34.1 Global Degenerative Disc Disease Treatment Market In 2030 - Countries Offering Most New Opportunities
• 34.2 Global Degenerative Disc Disease Treatment Market In 2030 - Segments Offering Most New Opportunities
• 34.3 Global Degenerative Disc Disease Treatment Market In 2030 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35 Degenerative Disc Disease Tretment Market, Conclusions And Recommendations

• 35.1 Conclusions
• 35.2 Recommendations
  • 35.2.1 Product
  • 35.2.2 Place
  • 35.2.3 Price
  • 35.2.4 Promotion
  • 35.2.5 People

36 Appendix

• 36.1 Geographies Covered
• 36.2 Market Data Sources
• 36.3 Research Methodology
• 36.4 Currencies
• 36.5 The Business Research Company
• 36.6 Copyright and Disclaimer